Research on NSCLC remains limited, although multiple cytokines are being investigated in combination with immunotherapies, particularly PD-1/PD-L1 inhibitors, for a variety of solid tumors [91]. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.